Better2Know Cancer screening

Myeloma (Bone Marrow) Cancer Screen

This clinic-based blood test screens for markers linked to myeloma, a type of bone marrow cancer, combining a full blood count, protein electrophoresis, immunoglobulins and other measures into one screen. It suits people who prefer an in-person clinic appointment.

Sample
Blood
Collection
Venous draw at clinic; also home kit £295
Results in
5 days
Biomarkers
1
Tests for
  • Myeloma Screen

Test specifications

Provider
Better2Know
Sample type
blood
Collection method
venous draw at clinic; also home kit £295
Turnaround time
5 days
Biomarkers tested
1
At-home test
No
Doctor reviewed
No
Gender focus
Both

What's tested

1 biomarker as listed by Better2Know.

  • Myeloma Screen

About this test

Myeloma is a cancer of the bone marrow that can affect the skull, ribs, spine and pelvis. According to the provider, this screen combines a full blood count with a five-part differential, erythrocyte sedimentation rate, protein electrophoresis, an immunoglobulin test, Bence-Jones protein from a urine sample, and a wider biochemistry profile. These measures are commonly used to flag abnormalities that may need further investigation; the test does not diagnose myeloma or any other condition on its own.

There is no comparison group listed for this test, so we cannot benchmark it against a direct peer. Against the wider set of cancer screening tests we track, £395 is well above the £75 median for that category. Better2Know also offers a home nurse-visit version of the same screen for £295.

The scores show a clearly presented listing, but only moderate clinical depth for the category, and the biggest markdown is on price, which sits well above the cancer screening median. It also loses marks on results and follow-up, because it is not doctor-reviewed as standard, though the provider says abnormal results should be discussed with a doctor.

Who is it for?

This suits people who want this myeloma-related screen done in person at a clinic rather than through a home nurse visit. Better2Know also offers the same combined panel as a home nurse-visit kit for £295, if you would rather avoid a clinic appointment. There is no comparison group listed for this test, so if clinical depth for the price matters most to you, it is worth checking how this screen's combined measures compare with other cancer screening panels. If you have symptoms or a relevant family history, it is worth discussing with a GP alongside any testing.

How it works

A blood sample is taken by venous draw at a Better2Know clinic. According to the provider, a urine sample is also collected to test for Bence-Jones protein. The samples are sent to the laboratory, where the full panel described above is analysed. Results are typically available within five days of the samples reaching the laboratory, through your secure online patient area. The sheet does not state that results are doctor-reviewed as standard.

Pros & cons

Pros

  • Combines several measures, including protein electrophoresis and Bence-Jones protein, into one screen.
  • In-person clinic appointment, if you would rather not do a home nurse visit.
  • Full description and turnaround time are published upfront.

Cons

  • £395 is around 427% above the £75 median for similarly sized cancer screening tests.
  • Results are not doctor-reviewed as standard.
  • The same combined panel is also available as a lower-cost home nurse-visit kit for £295.

Our editorial score

Compare Health Test Score Myeloma screen priced well above category median
Editorial confidence: 9.0/10

This clinic-based myeloma screen combines several blood and urine measures into one panel, with results in five days. At £395 it runs well above the £75 median for the cancer screening tests we track, and a home nurse-visit version of the same screen is available from Better2Know for £295.

Score breakdown

  • Clarity and documentation 9.0/10

    The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 6.4/10

    1 biomarkers, placing it in the 32nd percentile of cancer screening tests we track.

  • Collection convenience 8.0/10

    A finger-prick sample you take at home; with a venous or clinic option as well; results in around 5 days, in line with or faster than similar tests.

  • Results and follow-up 3.0/10

    Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.

  • Trust signals 6.5/10

    Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.

  • Value for money 2.0/10

    £395.00 against a median of £75.00 for the 19 similarly sized cancer screening tests we track (+427%).

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

More in Cancer screening

View all →
Selph

qFIT Bowel Cancer Screening Test

Priced close to the FIT test group median

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10
£59.00
Full review →